Aptevo Therapeutics Inc (APVO)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
2.41 +0.03 (+1.26%) 03/14/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 2.47 +0.06 (+2.49%) 16:44 ET
for Fri, Mar 14th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | 12-2013 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -51,115 | -53,337 | N/A | N/A |
| Depreciation Amortization | 2,021 | 666 | N/A | N/A |
| Income taxes - deferred | 117 | N/A | N/A | N/A |
| Accounts receivable | -6,134 | -8 | N/A | N/A |
| Accounts payable and accrued liabilities | 820 | 121 | N/A | N/A |
| Other Working Capital | 592 | 342 | N/A | N/A |
| Other Operating Activity | 6,692 | 824 | 0 | 0 |
| Operating Cash Flow | $-47,007 | $-51,392 | $N/A | $N/A |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -989 | -1,021 | N/A | N/A |
| Net Acquisitions | -47,811 | N/A | N/A | N/A |
| Investing Cash Flow | $-48,800 | $-1,021 | $N/A | $N/A |
| Cash Flows From Financing Activities | ||||
| Other Financing Activity | 99,400 | 52,413 | 0 | 0 |
| Financing Cash Flow | $99,400 | $52,413 | $N/A | $N/A |
| End Cash Position | 3,593 | N/A | N/A | N/A |
| Net Cash Flow | $3,593 | $N/A | $N/A | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | -47,007 | -51,392 | N/A | N/A |
| Capital Expenditure | -989 | -1,021 | N/A | N/A |
| Free Cash Flow | -47,996 | -52,413 | 0 | 0 |